BRCA1 and neurofibromatosis type 1: For example, in neurofibromatosis type 1 patients, splicing mutations in NF1 represents the 40% of the amount of causative variants (17), whereas in hereditary breast/ovarian cancer, splicing aberrations in BRCA1/2 are about 49% (18).